Serum lipids NOS [lbpr]
Apolipoproteins [aapp, bacs]
Greek [popg]
postmenopausal [tmco]
Women [popg]
Association [menp]
Estrogen [horm, phsu, strd]
Estrogen [horm, phsu, strd]
Progestin [horm, phsu, strd]
tibolone [phsu, strd]
Raloxifene [orch, phsu]
therapy [ftcn]
Study [mnob]
Lipid [lipd]
Apolipoprotein [aapp, bacs]
Levels [qlco]
postmenopausal [tmco]
Women [popg]
Take [hlca]
Various [irda]
regimens [inpr]
Replacement therapy [topp]
therapy [ftcn]
Seven [qnco]
Eight [qnco]
postmenopausal [tmco]
Women [popg]
Menopause [phsf]
Clinic [hcro, mnob]
Department [orgt]
Obstetrics [bmod]
Gynaecology [bmod]
University [mnob, orgt]
Hospital [hcro, mnob]
Study [mnob]
cross sections [spco]
Design [acty]
Women [popg]
Users [humn]
Replacement therapy [topp]
Users [humn]
Following [tmco]
regimens [inpr]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
mg% [qnco]
cee [orch]
cee [orch]
mg/mg [qnco]
Plus [qlco]
medroxyprogesterone acetate [horm, phsu, strd]
cee [orch]
17beta estradiol [horm, phsu, strd]
mg/mg [qnco]
Plus [qlco]
Norethisterone acetate [horm, phsu, strd]
Neta [fngs]
tibolone 2.5 MG [clnd]
Raloxifene 60 MG [clnd]
Total Cholesterol [lbpr]
Cholesterol, LDL [bacs, strd]
Cholesterol, HDL [bacs, lipd]
Triglycerides [bacs, lipd]
Apolipoprotein A [aapp, bacs]
Apo-A [aapp, bacs]
Apolipoprotein B [aapp, bacs]
Assessed [acty]
Women [popg]
Grouped [spco]
Replacement [topp]
Regimen [topp]
Levels [qlco]
Lipid [lipd]
Apolipoproteins [aapp, bacs]
Compared [acty]
Group [idcn]
Women [popg]
Raloxifene [orch, phsu]
Group [idcn]
Old [tmco]
Long [qlco]
Adjustment [inbe]
Age [orga]
Duration [tmco]
Menopause [phsf]
Triglyceride level [lbtr]
tibolone [phsu, strd]
Neta [fngs]
Group [idcn]
mg dl [qnco]
Compared [acty]
Users [humn]
Total Cholesterol [lbpr]
therapy [ftcn]
Group [idcn]
Acquired [tmco]
Neta [fngs]
mg dl [qnco]
Compared [acty]
Users [humn]
mg dl [qnco]
LDLC [gngm]
cee [orch]
mg dl [qnco]
cee [orch]
mg dl [qnco]
Raloxifene [orch, phsu]
Group [idcn]
mg dl [qnco]
Compared [acty]
Users [humn]
mg dl [qnco]
cholesterol levels [lbpr]
Users [humn]
Users [humn]
mg dl [qnco]
tibolone [phsu, strd]
Group [idcn]
Cholesterol, HDL [bacs, lipd]
mg dl [qnco]
Apo-A [aapp, bacs]
Levels [qlco]
cee [orch]
Group [idcn]
mg dl [qnco]
tibolone [phsu, strd]
Group [idcn]
mg dl [qnco]
Compared [acty]
Users [humn]
mg dl [qnco]
Detected [fndg]
Group [idcn]
Concern [idcn]
Apolipoprotein B [aapp, bacs]
tibolone [phsu, strd]
therapy [ftcn]
Lower triglycerides [fndg]
Levels [qlco]
Apo-A [aapp, bacs]
Levels [qlco]
ERT [topp]
Continuous [idcn]
Combined therapy [topp]
Estrogen [horm, phsu, strd]
Progestin [horm, phsu, strd]
HRT [topp]
Raloxifene [orch, phsu]
Cholesterol, LDL [bacs, strd]
Continuous [idcn]
Combined [qlco]
HRT [topp]
Users [humn]
cee [orch]
Apo-A [aapp, bacs]
Levels [qlco]
Neta [fngs]
Lower triglycerides [fndg]
Levels [qlco]
Large [qnco]
Prospective Studies [resa]
randomized [resa]
Required [ftcn]
